June 9, 2020 | Cardiovascular
Speaker: Dr. Wayne Sodano
Cardiovascular disease is the leading cause of death and disability worldwide. Identifying risk factors for cardiovascular disease will enable clinicians to personalize therapy for dyslipidemia and other cardiovascular conditions according to each patient’s risk level and thereby maximize effectiveness.(1) This webinar discusses laboratory biomarkers for the assessment of cardiovascular disease risk.
Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, et al. American Association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Atherosclerosis. Endocrine Practice March/April 2012; Vol. 18: Suppl. 1.